Giuliano Rizzardini
Luigi Sacco Hospital(IT)ASST Fatebenefratelli Sacco(IT)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, HIV Research and Treatment, Hepatitis C virus research, HIV/AIDS Research and Interventions, HIV-related health complications and treatments
Most-Cited Works
- → Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study(2020)1,376 cited
- → Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression(2020)541 cited
- → COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?(2020)477 cited
- → Comparison of Changes in Bone Density and Turnover with Abacavir‐Lamivudine versus Tenofovir‐Emtricitabine in HIV‐Infected Adults: 48‐Week Results from the ASSERT Study(2010)409 cited
- → Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials(2018)373 cited
- → Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study